PSAT1 antibody (AA 1-363) (HRP)
Quick Overview for PSAT1 antibody (AA 1-363) (HRP) (ABIN8022462)
Target
See all PSAT1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-363
-
Purpose
- Anti-PSAT1 Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human PSAT1 recombinant protein (Position: M1-K363).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- PSAT1 (phosphoserine Aminotransferase 1 (PSAT1))
-
Alternative Name
- PSAT1
-
Background
-
Background: Phosphoserine aminotransferase (PSA), also known as phosphohydroxythreonine aminotransferase (PSAT), is an enzyme that in humans is encoded by the PSAT1 gene. This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants.
Gene Full Name: phosphoserine aminotransferase 1
-
Gene ID
- 29968
-
UniProt
- Q9Y617
-
Pathways
- Warburg Effect
Target
-